{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T13:13:11Z","timestamp":1770815591413,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T00:00:00Z","timestamp":1619654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T00:00:00Z","timestamp":1619654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1245\/s10434-021-09972-2","type":"journal-article","created":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T15:03:53Z","timestamp":1619708633000},"page":"6083-6096","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Ductal Carcinoma in Situ in Young Women: Increasing Rates of Mastectomy and Variability in Endocrine Therapy Use"],"prefix":"10.1245","volume":"28","author":[{"given":"David J.","family":"Byun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Peter","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Himanshu","family":"Nagar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naamit K.","family":"Gerber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,29]]},"reference":[{"key":"9972_CR1","unstructured":"National Comprehensive Cancer Network: Breast Cancer (Version 3.2019). Available at: http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast.pdf. Accessed 6 Apr 2020."},{"issue":"41","key":"9972_CR2","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1093\/jncimonographs\/lgq039","volume":"2010","author":"C Correa","year":"2010","unstructured":"Early Breast Cancer Trialists' Collaborative G, Correa C, McCale P. Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr. 2010;2010(41):162\u201377.","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"1","key":"9972_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S1470-2045(10)70266-7","volume":"12","author":"J Cuzick","year":"2011","unstructured":"Cuzick J, Sestak I, Pinder SE, et al. Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK\/ANZ DCIS trial. Lancet Oncol. 2011;12(1):21\u20139.","journal-title":"Lancet Oncol."},{"issue":"32","key":"9972_CR4","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.1200\/JCO.2014.56.2595","volume":"32","author":"F Warnberg","year":"2014","unstructured":"Warnberg F, Garmo H, Emdin S, et al. Effect of radiotherapy after breast-conserving surgery for ductal carcinoma in situ: 20 years follow-up in the randomized SweDCIS Trial. J Clin Oncol. 2014;32(32):3613\u20138.","journal-title":"J Clin Oncol."},{"key":"9972_CR5","doi-asserted-by":"crossref","unstructured":"EORTC Breast Cancer Coopeative Group, EORTC Radiotherapy Group, Bijker N, et al. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853\u2014a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol. 2006;24(21):3381\u20137.","DOI":"10.1200\/JCO.2006.06.1366"},{"issue":"7","key":"9972_CR6","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1001\/jamaoncol.2015.2510","volume":"1","author":"SA Narod","year":"2015","unstructured":"Narod SA, Iqbal J, Giannakeas V, Sopik V, Sun P. Breast cancer mortality after a diagnosis of ductal carcinoma in situ. JAMA Oncol. 2015;1(7):888\u201396.","journal-title":"JAMA Oncol."},{"issue":"6","key":"9972_CR7","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1093\/jnci\/djr027","volume":"103","author":"IL Wapnir","year":"2011","unstructured":"Wapnir IL, Dignam JJ, Fisher B, et al. Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J Natl Cancer Inst. 2011;103(6):478\u201388.","journal-title":"J Natl Cancer Inst."},{"issue":"12","key":"9972_CR8","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1200\/JCO.2010.34.0141","volume":"30","author":"DC Allred","year":"2012","unstructured":"Allred DC, Anderson SJ, Paik S, et al. Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24. J Clin Oncol. 2012;30(12):1268\u201373.","journal-title":"J Clin Oncol."},{"issue":"9","key":"9972_CR9","doi-asserted-by":"publisher","first-page":"e2017124","DOI":"10.1001\/jamanetworkopen.2020.17124","volume":"3","author":"V Giannakeas","year":"2020","unstructured":"Giannakeas V, Sopik V, Narod SA. Association of a diagnosis of ductal carcinoma in situ with death from breast cancer. JAMA Netw Open. 2020;3(9):e2017124.","journal-title":"JAMA Netw Open."},{"issue":"Suppl 2","key":"9972_CR10","doi-asserted-by":"publisher","first-page":"S154","DOI":"10.1016\/j.breast.2015.07.036","volume":"24","author":"SM Rosenberg","year":"2015","unstructured":"Rosenberg SM, Partridge AH. Management of breast cancer in very young women. Breast. 2015;24(Suppl 2):S154-158.","journal-title":"Breast."},{"issue":"19","key":"9972_CR11","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1093\/jnci\/djp271","volume":"101","author":"ST Hawley","year":"2009","unstructured":"Hawley ST, Griggs JJ, Hamilton AS, et al. Decision involvement and receipt of mastectomy among racially and ethnically diverse breast cancer patients. J Natl Cancer Inst. 2009;101(19):1337\u201347.","journal-title":"J Natl Cancer Inst."},{"issue":"3","key":"9972_CR12","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1001\/jamasurg.2016.4749","volume":"152","author":"R Jagsi","year":"2017","unstructured":"Jagsi R, Hawley ST, Griffith KA, et al. Contralateral prophylactic mastectomy decisions in a population-based sample of patients with early-stage breast cancer. JAMA Surg. 2017;152(3):274\u201382.","journal-title":"JAMA Surg."},{"issue":"5","key":"9972_CR13","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1056\/NEJMoa1412379","volume":"372","author":"PA Francis","year":"2015","unstructured":"Francis PA, Regan MM, Fleming GF, et al. Adjuvant ovarian suppression in premenopausal breast cancer. N Engl J Med. 2015;372(5):436\u201346.","journal-title":"N Engl J Med."},{"issue":"11","key":"9972_CR14","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1200\/JCO.2015.65.1869","volume":"34","author":"Y Sagara","year":"2016","unstructured":"Sagara Y, Freedman RA, Vaz-Luis I, et al. Patient prognostic score and associations with survival improvement offered by radiotherapy after breast-conserving surgery for ductal carcinoma in situ: a population-based longitudinal cohort study. J Clin Oncol. 2016;34(11):1190\u20136.","journal-title":"J Clin Oncol."},{"issue":"4","key":"9972_CR15","doi-asserted-by":"publisher","first-page":"e181100","DOI":"10.1001\/jamanetworkopen.2018.1100","volume":"1","author":"V Giannakeas","year":"2018","unstructured":"Giannakeas V, Sopik V, Narod SA. Association of radiotherapy with survival in women treated for ductal carcinoma in situ with lumpectomy or mastectomy. JAMA Netw Open. 2018;1(4):e181100.","journal-title":"JAMA Netw Open."},{"issue":"7","key":"9972_CR16","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1200\/JCO.2014.57.9029","volume":"33","author":"B McCormick","year":"2015","unstructured":"McCormick B, Winter K, Hudis C, et al. RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation. J Clin Oncol. 2015;33(7):709\u201315.","journal-title":"J Clin Oncol."},{"issue":"32","key":"9972_CR17","doi-asserted-by":"publisher","first-page":"5319","DOI":"10.1200\/JCO.2009.21.8560","volume":"27","author":"LL Hughes","year":"2009","unstructured":"Hughes LL, Wang M, Page DL, et al. Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group. J Clin Oncol. 2009;27(32):5319\u201324.","journal-title":"J Clin Oncol."},{"issue":"10","key":"9972_CR18","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1245\/s10434-010-1091-3","volume":"17","author":"K Yao","year":"2010","unstructured":"Yao K, Stewart AK, Winchester DJ, Winchester DP. Trends in contralateral prophylactic mastectomy for unilateral cancer: a report from the National Cancer Data Base, 1998\u20132007. Ann Surg Oncol. 2010;17(10):2554\u201362.","journal-title":"Ann Surg Oncol."},{"issue":"9","key":"9972_CR19","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1200\/JCO.2008.20.1681","volume":"27","author":"TM Tuttle","year":"2009","unstructured":"Tuttle TM, Jarosek S, Habermann EB, et al. Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. J Clin Oncol. 2009;27(9):1362\u20137.","journal-title":"J Clin Oncol."},{"issue":"12","key":"9972_CR20","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1093\/jnci\/djv263","volume":"107","author":"M Worni","year":"2015","unstructured":"Worni M, Akushevich I, Greenup R, et al. Trends in treatment patterns and outcomes for ductal carcinoma in situ. J Natl Cancer Inst. 2015;107(12):263.","journal-title":"J Natl Cancer Inst."},{"issue":"10","key":"9972_CR21","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1245\/s10434-009-0641-z","volume":"16","author":"AK Arrington","year":"2009","unstructured":"Arrington AK, Jarosek SL, Virnig BA, Habermann EB, Tuttle TM. Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer. Ann Surg Oncol. 2009;16(10):2697\u2013704.","journal-title":"Ann Surg Oncol."},{"issue":"10","key":"9972_CR22","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1245\/s10434-009-0547-9","volume":"16","author":"NB Jones","year":"2009","unstructured":"Jones NB, Wilson J, Kotur L, Stephens J, Farrar WB, Agnese DM. Contralateral prophylactic mastectomy for unilateral breast cancer: an increasing trend at a single institution. Ann Surg Oncol. 2009;16(10):2691\u20136.","journal-title":"Ann Surg Oncol."},{"issue":"33","key":"9972_CR23","doi-asserted-by":"publisher","first-page":"5203","DOI":"10.1200\/JCO.2007.12.3141","volume":"25","author":"TM Tuttle","year":"2007","unstructured":"Tuttle TM, Habermann EB, Grund EH, Morris TJ, Virnig BA. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol. 2007;25(33):5203\u20139.","journal-title":"J Clin Oncol."},{"issue":"9","key":"9972_CR24","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1200\/JCO.2013.52.2284","volume":"32","author":"R Jagsi","year":"2014","unstructured":"Jagsi R, Jiang J, Momoh AO, et al. Trends and variation in use of breast reconstruction in patients with breast cancer undergoing mastectomy in the United States. J Clin Oncol. 2014;32(9):919\u201326.","journal-title":"J Clin Oncol."},{"issue":"9","key":"9972_CR25","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1001\/jama.2014.10707","volume":"312","author":"AW Kurian","year":"2014","unstructured":"Kurian AW, Lichtensztajn DY, Keegan TH, Nelson DO, Clarke CA, Gomez SL. Use of and mortality after bilateral mastectomy compared with other surgical treatments for breast cancer in California, 1998\u20132011. JAMA. 2014;312(9):902\u201314.","journal-title":"JAMA."},{"issue":"8","key":"9972_CR26","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1158\/1940-6207.CAPR-09-0130","volume":"3","author":"M Yi","year":"2010","unstructured":"Yi M, Hunt KK, Arun BK, et al. Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy. Cancer Prev Res (Phila). 2010;3(8):1026\u201334.","journal-title":"Cancer Prev Res (Phila)."},{"issue":"3","key":"9972_CR27","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.breast.2009.04.003","volume":"18","author":"A Goodwin","year":"2009","unstructured":"Goodwin A, Parker S, Ghersi D, Wilcken N. Post-operative radiotherapy for ductal carcinoma in situ of the breast\u2014a systematic review of the randomised trials. Breast. 2009;18(3):143\u20139.","journal-title":"Breast."},{"issue":"5","key":"9972_CR28","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1186\/s13058-014-0442-6","volume":"16","author":"DG Evans","year":"2014","unstructured":"Evans DG, Barwell J, Eccles DM, et al. The Angelina Jolie effect: how high celebrity profile can have a major impact on provision of cancer related services. Breast Cancer Res. 2014;16(5):442.","journal-title":"Breast Cancer Res."},{"issue":"10","key":"9972_CR29","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1245\/s10434-009-0634-y","volume":"16","author":"CM Balch","year":"2009","unstructured":"Balch CM, Jacobs LK. Mastectomies on the rise for breast cancer: \u201cthe tide is changing.\u201d Ann Surg Oncol. 2009;16(10):2669\u201372.","journal-title":"Ann Surg Oncol."},{"issue":"9","key":"9972_CR30","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1245\/s10434-016-5202-7","volume":"23","author":"MS Sabel","year":"2016","unstructured":"Sabel MS, Dal Cin S. Trends in media reports of celebrities\u2019 breast cancer treatment decisions. Ann Surg Oncol. 2016;23(9):2795\u2013801.","journal-title":"Ann Surg Oncol."},{"issue":"7","key":"9972_CR31","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/gim.2013.181","volume":"16","author":"DL Borzekowski","year":"2014","unstructured":"Borzekowski DL, Guan Y, Smith KC, Erby LH, Roter DL. The Angelina effect: immediate reach, grasp, and impact of going public. Genet Med. 2014;16(7):516\u201321.","journal-title":"Genet Med."},{"issue":"1","key":"9972_CR32","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1177\/0272989X14556130","volume":"35","author":"SM Noar","year":"2015","unstructured":"Noar SM, Althouse BM, Ayers JW, Francis DB, Ribisl KM. Cancer information seeking in the digital age: effects of Angelina Jolie\u2019s prophylactic mastectomy announcement. Med Decis Making. 2015;35(1):16\u201321.","journal-title":"Med Decis Making."},{"issue":"6","key":"9972_CR33","doi-asserted-by":"publisher","first-page":"373","DOI":"10.7326\/0003-4819-159-6-201309170-00003","volume":"159","author":"SM Rosenberg","year":"2013","unstructured":"Rosenberg SM, Tracy MS, Meyer ME, et al. Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer: a cross-sectional survey. Ann Intern Med. 2013;159(6):373\u201381.","journal-title":"Ann Intern Med."},{"issue":"1","key":"9972_CR34","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13058-019-1143-y","volume":"21","author":"C Petridis","year":"2019","unstructured":"Petridis C, Arora I, Shah V, et al. Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50 years. Breast Cancer Res. 2019;21(1):58.","journal-title":"Breast Cancer Res."},{"issue":"10","key":"9972_CR35","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.5858\/133.10.1515","volume":"133","author":"SC Lester","year":"2009","unstructured":"Lester SC, Bose S, Chen YY, et al. Protocol for the examination of specimens from patients with invasive carcinoma of the breast. Arch Pathol Lab Med. 2009;133(10):1515\u201338.","journal-title":"Arch Pathol Lab Med."},{"issue":"3","key":"9972_CR36","doi-asserted-by":"publisher","first-page":"e493","DOI":"10.1002\/mgg3.493","volume":"7","author":"Y Liu","year":"2019","unstructured":"Liu Y, Ide Y, Inuzuka M, et al. BRCA1\/BRCA2 mutations in Japanese women with ductal carcinoma in situ. Mol Genet Genomic Med. 2019;7(3):e493.","journal-title":"Mol Genet Genomic Med."},{"issue":"6","key":"9972_CR37","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/bcr2160","volume":"10","author":"SC Formenti","year":"2008","unstructured":"Formenti SC, Demaria S. Local control by radiotherapy: is that all there is? Breast Cancer Res. 2008;10(6):215.","journal-title":"Breast Cancer Res."},{"issue":"5","key":"9972_CR38","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1002\/cncr.20085","volume":"100","author":"TW Yen","year":"2004","unstructured":"Yen TW, Hunt KK, Mirza NQ, et al. Physician recommendations regarding tamoxifen and patient utilization of tamoxifen after surgery for ductal carcinoma in situ. Cancer. 2004;100(5):942\u20139.","journal-title":"Cancer."},{"issue":"10","key":"9972_CR39","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.1245\/s10434-017-5930-3","volume":"24","author":"TT Nguyen","year":"2017","unstructured":"Nguyen TT, Hoskin TL, Day CN, Habermann EB, Goetz MP, Boughey JC. Factors influencing use of hormone therapy for ductal carcinoma in situ: a national cancer database study. Ann Surg Oncol. 2017;24(10):2989\u201398.","journal-title":"Ann Surg Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-021-09972-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-021-09972-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-021-09972-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T01:09:24Z","timestamp":1632445764000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-021-09972-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,29]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["9972"],"URL":"https:\/\/doi.org\/10.1245\/s10434-021-09972-2","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,29]]},"assertion":[{"value":"27 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"David J. Byun, S. Peter Wu, Himanshu Nagar and Naamit K. Gerber have no actual or potential conflicts of interest to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}},{"value":"Research data are based on the National Cancer Database and data transfer is not possible.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Sharing Agreement"}}]}}